Phase 2 Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Autism Spectrum Disorder (ASD), confirmed through a standard recognized assessment process
- You are male or female, aged between 18 and 65 years old
- You have noticeable difficulties with social interaction and communication, as measured by a specific scoring tool (a score of 66 or higher on the Social Responsiveness Scale)
Who may not be able to join:
- You have uncorrected problems with your eye movements, eye alignment, or vision, or have unusual eye features that could interfere with eye-tracking technology used in the trial
- You have a close blood relative (parent, sibling, or child) who has been diagnosed with a psychotic disorder or bipolar disorder, or you yourself have ever been diagnosed with one of these conditions
- You currently have a diagnosis of alcohol or drug use disorder (note: nicotine and caffeine are not included in this)
- You have any significant ongoing health condition that is not stable or well-controlled (confirm with trial site)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-332-282-0479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in 11-point Numerical Rating Scale (NRS) scores
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.